Explore this research category across breast cancer datasets
| RNA Name | Mechanism of Action | Effect on Cancer | Cancer Type | Reference |
|---|---|---|---|---|
|
miR-128-3p
miRNA |
Targets CD98hc, induces ferroptosis | Promotes ferroptosis and reduces tumor burden | Breast Cancer |
PubMed
Reference PMID: 38734268 |
|
miR-376c-3p
miRNA |
Targets SLC7A11 to regulate ferroptosis | Inhibits ferroptosis and supports tumor growth | Breast Cancer |
PubMed
Reference PMID: 38318853 |
|
miR-5096
miRNA |
Targets SLC7A11 and induces ferroptotic cell death | Induces ferroptosis and reduces invasion | Breast Cancer |
PubMed
Reference PMID: 34571083 |
|
miR-324-3p
miRNA |
Targets GPX4 to induce ferroptosis | Promotes ferroptosis and inhibits proliferation | Breast Cancer |
PubMed
Reference PMID: 33522578 |
|
miR-106a-5p
miRNA |
Regulates STAT3 to inhibit ferroptosis | Supports progression by attenuating ferroptosis | Breast Cancer |
PubMed
Reference PMID: 33686957 |
|
miR-382-5p
miRNA |
Down regulate the expression of SLC7A11 | Block lidocaine induced ferroptosis | Breast Cancer |
PubMed
Reference PMID: 34122108 |
|
miR-133a
miRNA |
Decreased levels of ferritin light chain (FTL) protein | Increases sensitivity for doxorubicin and cisplatin induced ferroptosis | Breast Cancer |
PubMed
Reference PMID: 23969999 |
|
miR-141-3p
miRNA |
Upregulate SLC7A11-GSH-GPX4 signaling pathway | Inhibit ferroptosis | Breast Cancer |
PubMed
Reference PMID: 39308683 |
|
miR-199a-3p
miRNA |
Not reported in ferroptosis context | Tumor suppressor in TNBC: inhibits proliferation/migration and reverses cisplatin resistance via targeting BRCA1 | Breast Cancer |
PubMed
Reference PMID: 35422914 |
|
miR-19b-3p
miRNA |
Not reported | Oncogenic: enhances BC metastasis/invasion by targeting tumor suppressor MYLIP | Breast Cancer |
PubMed
Reference PMID: 28969074 |